Aster DM Healthcare Ltd
Fundamental Score
Aster DM Healthcare Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ASTERDM across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Strong Interest Coverage (5.41x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Cash Generation (₹2417.08 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 45.04%)
Observation: Significant professional investor participation indicates quality recognition.
Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.
Risk Factors
8 factors identified
Below-Average Return on Equity (8.26%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 94.51x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Limited Growth History (-13.71% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Earnings Growth (-7.24% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (-7.24% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
High Share Pledging Risk (40.66%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns or margin calls.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Financial Statements
Comprehensive financial data for Aster DM Healthcare Ltd
About ASTERDM
Business Overview
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare services in India. It operates through Hospitals, Clinics, Wholesale Pharmacies, and Others segments. The company operates hospitals, clinic, and in-house pharmacies at the hospitals and clinics. It also offers healthcare consultancy and other services. In addition, the company operates retail pharmacies and optical outlets. Aster DM Healthcare Limited was founded in 1987 and is based in Bengaluru, India.
Company Details
Key Leadership
Corporate Events
Latest News
ASTERDM Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Aster DM Healthcare Ltd (ASTERDM)?
As of 21 Jan 2026, 08:49 am IST, Aster DM Healthcare Ltd (ASTERDM) is currently trading at ₹560.85. The stock has a market capitalization of ₹34.69K (Cr).
Is ASTERDM share price Overvalued or Undervalued?
ASTERDM is currently trading at a P/E ratio of 94.51x, compared to the industry average of 52.84x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Aster DM Healthcare Ltd share price?
Key factors influencing ASTERDM's price include its quarterly earnings growth (Sales Growth: 10.20%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Aster DM Healthcare Ltd a good stock for long-term investment?
Aster DM Healthcare Ltd shows a 5-year Profit Growth of -7.24% and an ROE of 8.26%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.46 before investing.
How does Aster DM Healthcare Ltd compare with its industry peers?
Aster DM Healthcare Ltd competes with major peers in the Hospital. Investors should compare ASTERDM's P/E of 94.51x and ROE of 8.26% against the industry averages to determine its competitive standing.
What is the P/E ratio of ASTERDM and what does it mean?
ASTERDM has a P/E ratio of 94.51x compared to the industry average of 52.84x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹95 for every ₹1 of annual earnings.
How is ASTERDM performing according to Bull Run's analysis?
ASTERDM has a Bull Run fundamental score of 15.4/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ASTERDM belong to?
ASTERDM operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Aster DM Healthcare Ltd.
What is Return on Equity (ROE) and why is it important for ASTERDM?
ASTERDM has an ROE of 8.26%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Aster DM Healthcare Ltd generates profits from shareholders' equity.
How is ASTERDM's debt-to-equity ratio and what does it indicate?
ASTERDM has a debt-to-equity ratio of 0.46, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is ASTERDM's dividend yield and is it a good dividend stock?
ASTERDM offers a dividend yield of 0.75%, which means you receive ₹0.75 annual dividend for every ₹100 invested.
How has ASTERDM grown over the past 5 years?
ASTERDM has achieved 5-year growth rates of: Sales Growth -13.71%, Profit Growth -7.24%, and EPS Growth -7.24%.
What is the promoter holding in ASTERDM and why does it matter?
Promoters hold 40.39% of ASTERDM shares, with 40.66% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ASTERDM's market capitalization category?
ASTERDM has a market capitalization of ₹34688 crores, placing it in the Large-cap category.
How volatile is ASTERDM stock?
ASTERDM has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ASTERDM?
ASTERDM has a 52-week high of ₹N/A and low of ₹N/A.
What is ASTERDM's operating profit margin trend?
ASTERDM has a 5-year average Operating Profit Margin (OPM) of 14.86%, indicating the company's operational efficiency.
How is ASTERDM's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 10.20% and YoY Profit Growth of 13.83%.
What is the institutional holding pattern in ASTERDM?
ASTERDM has FII holding of 18.72% and DII holding of 26.32%. Significant institutional holding often suggests professional confidence in the stock.